See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420030_2014_Targeted_Medical_Pharma_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420030, Targeted Medical Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,629,518 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,132,649 |
| 2 | PropertyPlantAndEquipmentNet | 235,586 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 11,260,623 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 754,828 |
| 7 | CostOfGoodsAndServicesSold | 2,989,305 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,178,598 |
| 9 | ResearchAndDevelopmentExpense | 228,605 |
| 10 | remainder_Expenses | 5,666,902 |
| 11 | remainder_Revenues | 9,555,562 |
| 12 | remainder_NetIncome | 170,230 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,997,753 |
| 1 | Liabilities | 12,015,451 |
| 2 | Expenses | 19,063,410 |
| 3 | Revenues | 9,555,562 |
| 4 | StockholdersEquity | -7,017,698 |
| 5 | NetIncome | -9,337,618 |
| 6 | ComprehensiveNetIncome | -9,337,618 |
| 7 | BaseVar | 22,901,203 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.90 |
| 9 | EconomicCapitalRatio | 0.721 |
Edgar->Model Mapping
Feature Distribution
Change over Time
